GILD
Gilead Sciences Inc
Price:  
97.99 
USD
Volume:  
6,131,902.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Gilead WACC - Weighted Average Cost of Capital

The WACC of Gilead Sciences Inc (GILD) is 8.0%.

The Cost of Equity of Gilead Sciences Inc (GILD) is 8.95%.
The Cost of Debt of Gilead Sciences Inc (GILD) is 4.25%.

Range Selected
Cost of equity 7.70% - 10.20% 8.95%
Tax rate 20.20% - 22.90% 21.55%
Cost of debt 4.00% - 4.50% 4.25%
WACC 6.9% - 9.1% 8.0%
WACC

Gilead WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.83 0.96
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.70% 10.20%
Tax rate 20.20% 22.90%
Debt/Equity ratio 0.21 0.21
Cost of debt 4.00% 4.50%
After-tax WACC 6.9% 9.1%
Selected WACC 8.0%